UH Cancer Center ACCRUAL Event Celebrates Community Partners
April 10, 2019
HONOLULU – The University of Hawaiʻi. Cancer Center proudly celebrates the first Annual Cancer Clinical Research Accrual Leaders (ACCRUAL) event. The ACCRUAL event recognizes the clinical trial coordination and administration efforts of the UH Cancer Center’s community partners.
The UH Cancer Center coordinates clinical trials through a robust network on Oʻahu including the Hawaiʻi Cancer Consortium with oversight of trials at The Queen's Health Systems, Hawaiʻi Pacific Health hospitals, Kuakini Health System and numerous private practitioners statewide.
Awardees were recognized for efforts that included reviewing the validity of clinical trial protocols, facilitating clinical research to improve patient care, and for successfully enrolling patients in both therapeutic and non-therapeutic clinical trials.
“We realize that they are going beyond their usual duties and we want to acknowledge them for that,” said Jessica Rhee, MD, medical director of the UH Cancer Center Clinical Trials Office. “We could not do what we do in clinical research without these community partners and we want to hold an event to recognize them, to say thank you and to celebrate the successes from the previous year.”
These efforts to improve cancer care and treatments for the residents of Hawaiʻi contribute to the UH Cancer Center’s 20BY25 educational campaign goal to achieve enrollment to cancer clinical trials of 20 percent of all individuals with newly diagnosed & relapsed cancers each year by 2025. The ACCRUAL event celebrates movement toward this goal.
“This whole research program gives patients security in knowing their doctors are looking out for their best interest. It lets the patients know that there is support here in Hawaiʻi for their care and I think that’s another wonderful thing that the UH Cancer Center provides for them,” said Kenneth Sumida, MD, Hawaii Oncology, Inc., winner of a Gold Accrual Award.
Below is a list of the community partners recognized at the event for their efforts in the following areas:
UH Cancer Center ACCRUAL Event Celebrates Community Partners
April 10, 2019
HONOLULU – The University of Hawaiʻi. Cancer Center proudly celebrates the first Annual Cancer Clinical Research Accrual Leaders (ACCRUAL) event. The ACCRUAL event recognizes the clinical trial coordination and administration efforts of the UH Cancer Center’s community partners.
The UH Cancer Center coordinates clinical trials through a robust network on Oʻahu including the Hawaiʻi Cancer Consortium with oversight of trials at The Queen's Health Systems, Hawaiʻi Pacific Health hospitals, Kuakini Health System and numerous private practitioners statewide.
Awardees were recognized for efforts that included reviewing the validity of clinical trial protocols, facilitating clinical research to improve patient care, and for successfully enrolling patients in both therapeutic and non-therapeutic clinical trials.
“We realize that they are going beyond their usual duties and we want to acknowledge them for that,” said Jessica Rhee, MD, medical director of the UH Cancer Center Clinical Trials Office. “We could not do what we do in clinical research without these community partners and we want to hold an event to recognize them, to say thank you and to celebrate the successes from the previous year.”
These efforts to improve cancer care and treatments for the residents of Hawaiʻi contribute to the UH Cancer Center’s 20BY25 educational campaign goal to achieve enrollment to cancer clinical trials of 20 percent of all individuals with newly diagnosed & relapsed cancers each year by 2025. The ACCRUAL event celebrates movement toward this goal.
“This whole research program gives patients security in knowing their doctors are looking out for their best interest. It lets the patients know that there is support here in Hawaiʻi for their care and I think that’s another wonderful thing that the UH Cancer Center provides for them,” said Kenneth Sumida, MD, Hawaii Oncology, Inc., winner of a Gold Accrual Award.
Each hospital and private office nominated a staff member who facilitated clinical research and contributed significantly to care of patients on clinical trials
Tim Egante, CMA (Island Urology)
Christine Hoover, RN (Tripler Army Medical Center)
Shady Kaleikau, CMA (Hawaii Oncology, Inc.)
Robyn Morse, CCRC (Hawaii Pacific Health – adult oncology)
Kelly Nelsen, RN, MPH (The Queen's Medical Center)
Dee Ann Omatsu, MS, APRN (Hawaii Pacific Health – pediatric oncology)
The University of Hawaiʻi Cancer Center is dedicated to saving lives in Hawaiʻi and the Pacific, and inspiring hope by working to conquer cancer. The flagship priority is to understand and address cancer health disparities. The center strives to achieve this through research, education, patient care, and community outreach, focusing on the unique and diverse ethnic, cultural, and environmental characteristics of Hawaiʻi and the Pacific.
The UH Cancer Center is one of only 73 institutions designated by the National Cancer Institute (NCI), representing a significant mark of excellence, and is the only NCI-designated cancer center in Hawaiʻi and the Pacific. The center contributes more than $57 million to Hawaiʻi's economy through scientific research, clinical trials, and other activities.
As part of the University of Hawaiʻi at Mānoa, the UH Cancer Center operates out of facilities located in Kakaʻako. The center directly employs more than 300 faculty and staff, with an additional 200 affiliate members and cooperative agreements with organizations that are part of the Hawaiʻi Cancer Consortium. The consortium includes The Queen’s Health Systems, Hawaiʻi Pacific Health, Kuakini Medical Center, Adventist Health Castle, Hawaiʻi Medical Service Association (HMSA), and the John A. Burns School of Medicine (JABSOM), all working together with the UH Cancer Center to advance cancer research and treatment in the state.
